The human gut contains trillions of bacteria, known as the microbiota, which play a crucial role in digesting food and regulating the immune system. Multiple studies show certain bacteria and their metabolites are involved in triggering cancer, allowing it to develop, and/or making cancers treatment-resistant. However, the complex effects of prenatal and postnatal microbial exposure on adult health and disease outcomes remain unclear. Now, a study from researchers at Georgia State University shows exposure to microbiota in the early stages of life plays a crucial role in inhibiting the development of colon cancer in adulthood. The team states until now, the effects of prenatal and early postnatal microbial exposure on adult health and disease outcomes have received limited research. The study is published in the journal Cancer Immunology Research.
Previous studies have shown gut microbiota are instrumental in promoting normal body function and a stable immune system in the host, however, the research has involved later stage life studies due to the difficulty of studying microbiota in utero or in newborns. Humans are initially exposed to microbiota through their mothers when they are born, either through delivery via the birth canal or Caesarean section. The current study investigates whether microbiota in this early period influences disease outcomes in adulthood.
The current study compares two groups of mice providing a model of colon cancer. The first group of mice were born to germ-free mothers and raised under germ-free conditions until weaning, after which they were transferred to normal conditions and exposed to normal microbiota. The second group of mice were born to normal mothers and then bred under regular conditions with microbiota. Results show the mice raised in the microbiota-free environment had much larger and many more tumors in the colon. Data findings show the absence of microbiota in early life results in enhanced pro-inflammatory gene expression and accumulation of immune cells called myeloid-derived suppressor cells known to suppress other immune cells helping to limit or kill tumors.
The lab explains myeloid-derived suppressor cells accumulate inside the growth to suppress new, incoming immune cells attempting to kill the cancer, allowing the tumor to grow bigger in size and increases numbers. The group verified their results by blocking a specific pathway responsible for recruiting myeloid-derived suppressor cells to completely reverse the enhanced size and number of tumors in ex-germ-free mice.
The team surmises their findings highlight the crucial role of early life microbial exposure in establishing intestinal microbial homeostasis which is instrumental in restraining colon cancer in adulthood. For the future, the researchers state their results could provide insight into how the composition of microbiota in mothers and babies may control many inflammatory genes and susceptibility to diseases, including cancers, later in life.
Source: Georgia State University
Get Healthinnovations delivered to your inbox:
Michelle is a health industry veteran who taught and worked in the field before training as a science journalist.
Featured by numerous prestigious brands and publishers, she specializes in clinical trial innovation--expertise she gained while working in multiple positions within the private sector, the NHS, and Oxford University.